A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis

This study has been terminated.

( Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative glucocorticosteroid dosage )

Study NCT00076726 Information provided by Centocor, Inc.

First Received: February 2, 2004 Last Updated: May 16, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been terminated.
Study Completion Date:	July 2005
Estimated Primary Completion Date:	No date given

Publications:

Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU; Infliximab-GCA Study Group. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med. 2007 May 1;146(9):621-30. Summary for patients in: Ann Intern Med. 2007 May 1;146(9):I12.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Visvanathan S, Rahman MU, Hoffman GS, Xu S, García-Martínez A, Segarra M, Lozano E, Espígol-Frigolé G, Hernández-Rodríguez J, Cid MC. Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study. Rheumatology (Oxford). 2011 Nov;50(11):2061-70. Epub 2011 Aug 25.

Back to top of Main Content